Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Vopr Onkol ; 56(2): 191-5, 2010.
Article in Russian | MEDLINE | ID: mdl-20552896

ABSTRACT

Previously, significant increase in survival in locally-advanced rectal cancer as a result of heated intraoperative intraperitoneal chemotherapy was reported. Our study used cisplatin 0.5 mg/ml (0.05 per cent solution) in the culture of pharyngeal epidermoid carcinoma (PEC) cells (HEP-2) and A-549 culture of lung carcinoma cells. The number of viable cells was estimated colorimetrically after 24 and 48 hr incubation. 50%-rise in inhibition of culture growth was assumed to be biologically significant. Forty-eight hours after inoculation, single dose of cisplatin 8 mg/kg was injected in mice bearing transplanted lung carcinoma of Lewis (LLC). That was followed by death of tumor cells. Preheating (45 deg. C, 1 hr) did not influence either the cytostatic or therapeutic effect of cisplatin in vivo.That procedure inhibited tumor growth by 7-8% and the effect did not wear off until day 11 or longer. Survival in LLC-bearing mice rose by 26% which pointed to the advantages offered by heated cytostatic chemotherapy.


Subject(s)
Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Hyperthermia, Induced , Rectal Neoplasms/therapy , Adenocarcinoma/therapy , Animals , Antineoplastic Agents/administration & dosage , Carcinoma, Lewis Lung/therapy , Carcinoma, Squamous Cell/therapy , Cell Line, Tumor , Chemotherapy, Adjuvant , Cisplatin/administration & dosage , Colorimetry , Drug Administration Schedule , Humans , Intraoperative Period , Lung Neoplasms/therapy , Male , Mice , Mice, Inbred C57BL , Pharyngeal Neoplasms/therapy , Rectal Neoplasms/drug therapy , Rectal Neoplasms/surgery , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...